Related Experiment Video
Updated: Sep 6, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
The Effects of Smoking Status on Patient Outcomes in Pulmonary Rehabilitation
Sulamunn R M Coleman1, Diann E Gaalema, Raisha Ismail
1Author Affiliations: Vermont Center on Behavior and Health, University of Vermont, Burlington, Vermont (Drs Coleman, Gaalema, and Menson); Department of Psychiatry, University of Vermont, Burlington, Vermont (Dr Coleman); Department of Medicine, University of Vermont, Burlington, Vermont (Dr Ismail); Veterans Health Administration Office of Rural Health, Veterans Rural Health Resource Center-White River Junction, White River Junction, Vermont (Dr Coleman); Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama (Mr Zhang); and Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, Texas (Dr Gaalema).
Purpose:
This study examined the effects of smoking status upon pulmonary rehabilitation (PR) entry (current vs never/former) on clinical outcomes of PR using the American Association of Cardiovascular and Pulmonary Rehabilitation PR Registry.
Methods:
Participants with chronic obstructive pulmonary disease (N = 41,087) were from 319 PR programs in the US contributing data between 2013 and 2021. Baseline characteristics included demographics (age, sex, race, education, insurance), body mass index, and smoking status (current vs former/never). Outcomes included the number of PR sessions attended, functional capacity (6-minute walk distance [6MWD]), depression and anxiety symptoms, and dyspnea.
Results:
Current smoking was reported by 14% of participants. Compared to those who never or formerly smoked, those currently smoking were younger (64.1 ± 8.8 vs 70.8 ± 8.9 years), more likely to have Medicaid (17% vs 7%), had lower body mass index (28.3 ± 8.2 vs 30.0 ± 7.9 kg/m2), greater 6MWD (906.9 ± 343.0 vs 841.3 ± 350.6 ft), and higher depression (8.5 ± 6.1 vs 6.3 ± 5.3) and anxiety (6.9 ± 4.6 vs 5.5 ± 4.3) symptoms. At PR completion, those who smoke attended fewer sessions (14.9 ± 10.8 vs 18.7 ± 10.8 sessions), yet had similar improvements in 6MWD, anxiety symptoms, and dyspnea, but less improvement in depression symptoms (+0.52 [95% CI, 0.35-0.69]) compared to those who never or formerly smoked.
Conclusion:
Despite attending fewer PR sessions, patients with chronic obstructive pulmonary disease who currently smoke have clinically significant improvements in functional capacity, anxiety symptoms, and dyspnea comparable to patients who never or formerly smoked, yet their depression symptoms remain higher at program completion. Thus, PR programs should not restrict entry based on smoking status.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease II: Emphysema